“`
Symptoms of CCDC39 Gene Primary Ciliary Dyskinesia Type 14 Genetic Test
Primary Ciliary Dyskinesia (PCD) is a rare genetic disorder that affects the cilia, tiny hair-like structures that line the airways, ears, and other parts of the body. The CCDC39 gene has been identified as one of the genetic causes of PCD, specifically linked to Type 14 of the condition. Recognizing the symptoms of CCDC39 Gene Primary Ciliary Dyskinesia Type 14 is crucial for early diagnosis and treatment.
One of the hallmark symptoms of CCDC39-related PCD is chronic respiratory infections starting from a young age. These infections are due to the impaired movement of the cilia, which are unable to effectively clear mucus and debris from the airways. Other common symptoms include:
- Nasal congestion and sinus infections that are persistent and difficult to treat.
- A wet cough that is present from early childhood and persists throughout life.
- Ear infections, which can lead to hearing loss if not properly managed.
- Situs inversus or situs ambiguous, conditions where the internal organs are mirrored from their normal positions or have an abnormal arrangement.
- Infertility issues may also be a concern in adulthood due to impaired cilia function in the reproductive system.
It’s important to note that symptoms can vary significantly from person to person, and not all individuals with the CCDC39 gene mutation will experience all of these symptoms.
CCDC39 Gene Primary Ciliary Dyskinesia Type 14 Genetic Test
To confirm a diagnosis of CCDC39-related PCD, genetic testing is required. The CCDC39 Gene Primary Ciliary Dyskinesia Type 14 Genetic Test offered by DNA Labs UAE is designed to identify mutations in the CCDC39 gene that are responsible for the condition. This test is crucial for individuals showing symptoms of PCD, as it can provide a definitive diagnosis and guide treatment and management strategies.
The cost of the CCDC39 Gene Primary Ciliary Dyskinesia Type 14 Genetic Test is 4400 AED. While the cost may seem significant, the value of a precise diagnosis cannot be overstated. It enables targeted treatment, informs family planning decisions, and helps connect patients with appropriate support networks and resources.
Early diagnosis and intervention are key to managing PCD and improving quality of life. If you or a loved one are experiencing symptoms consistent with Primary Ciliary Dyskinesia, consider speaking with a healthcare professional about the possibility of genetic testing. For more information on the CCDC39 Gene Primary Ciliary Dyskinesia Type 14 Genetic Test, please visit DNA Labs UAE.
“`
